Head-to-head study demonstrating Giotrif (afatinib) significantly impro
LUX-Lung 7 trial showed afatinib significantly reduced the risk of lung canc...
2016-04-14
文传商讯
The Lancet Respiratory Medicine:New analysis shows only minority of COP
• New post-hoc analysis shows routine eosinophil blood test could help ...
2016-04-09
文传商讯
Giotrif (afatinib) approved in Europe as new oral treatment option for
Approval provides a new oral treatment option for patients with the second l...
2016-04-08
文传商讯
Interim Phase III Data Show Praxbind® (idarucizumab) Reverses Dabig
A single 5g dose of idarucizumab immediately reversed the anticoagulant effe...
2016-04-06
文传商讯
Boehringer Ingelheim launches RE-COVERY DVT/PE TM: global observational
First patient enrolled in RE-COVERY DVT/PE™Involving 14,000 patients w...
2016-03-24
文传商讯
Oral Ozanimod Showed Histologic Improvements in Patients with Ulcerativ
In patients with moderate to severe ulcerative colitis, histologic improveme...
2016-03-21
文传商讯
Oral OTEZLA® (apremilast) Data from Open-Label Phase of ESTEEM and
Pooled ESTEEM 1 and 2 182-week data will report on long-term exposure of OT...
2016-03-08
文传商讯
SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Tr
SPIRIVA® RESPIMAT® is the first new class of inhaled medicine approv...
2016-02-14
文传商讯
Merck and Pfizer Advance Clinical Development Program with Two Addition
Initiation of Phase III JAVELIN Ovarian 200 trial investigating avelumab as ...
2016-01-07
文传商讯
